Sale of 17,279 shares at $82.2104 per share.
Reporting Person Kumar Neil · Officer Title Chief Executive Officer · Transaction Code S
Traded Aug 18, 2026 · Disclosed Aug 20, 2026
Source: SEC Form 4 · 0001470831-26-000848 · filed 2026-08-20 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "BridgeBio Pharma, Inc. (BBIO)." Disclosed 2026-08-20. https://desqlong.com/cards/0001470831-26-000848-2 (retrieved 2026-09-26).